13F filing recap · Q2 2024

What did Patient Capital Management buy in Q2 2024?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.88B

Positions

Estimated turnover

18.5%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

EVRIEveri Holdings Inc$12.29Mreported value+1.46M shares SPYSPDR S&P 500 ETF Trust$401.7Kreported value+738 shares

Increased positions

NVDANvidia Corp$74.85Mreported value+545.2K shares+899.6%PPLIIac Inc.$74.84Mreported value+160.2K shares+11.1%BIIBBiogen Inc.$59.64Mreported value+39.4K shares+18.1%NCLHNorwegian Cruise Line Holdings Ltd.$53.31Mreported value+423.7K shares

Reduced positions

AMZNAmazon.com Inc$122.08Mreported value-12.3K shares-1.9%GOOGLAlphabet Inc.$109.52Mreported value-259 shares-0.0%CCitigroup Inc$105.54Mreported value-114.0K shares-6.4%EXPEExpedia Group, Inc.$90.21Mreported value-13.6K shares

Exited positions

COFCapital One Financial Corp$37.59Mprior reported value-252.5K shares-100.0%RKTRocket Companies, Inc.$2.08Mprior reported value-142.8K shares-100.0%VNTVontier Corporation$1.36Mprior reported value-30.0K shares-100.0%FANGDiamondback Energy, Inc.$594.5Kprior reported value-3.0K shares